Market closed

Vir Biotechnology/VIR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Vir Biotechnology

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Ticker

VIR
Trading on

Industry

Biotechnology

Employees

587

VIR Metrics

BasicAdvanced
$1B
Market cap
-
P/E ratio
-$3.58
EPS
0.48
Beta
-
Dividend rate
$1B
0.48
$13.09
$7.12
784K
12.506
12.014
6.628
7.987
-16.55%
-29.78%
13.001
0.72
0.74
-2.235
-83.93%
82.22%
-24.42%
15.38%

What the Analysts think about VIR

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Vir Biotechnology stock.

VIR Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

VIR Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy VIR

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Vir Biotechnology stock?

Vir Biotechnology (VIR) has a market cap of $1B as of October 13, 2024.

What is the P/E ratio for Vir Biotechnology stock?

The price to earnings (P/E) ratio for Vir Biotechnology (VIR) stock is 0 as of October 13, 2024.

Does Vir Biotechnology stock pay dividends?

No, Vir Biotechnology (VIR) stock does not pay dividends to its shareholders as of October 13, 2024.

When is the next Vir Biotechnology dividend payment date?

Vir Biotechnology (VIR) stock does not pay dividends to its shareholders.

What is the beta indicator for Vir Biotechnology?

Vir Biotechnology (VIR) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.